Home Tools
Log in
Cart

Search Result

Search Results for " pkc "

20

Compounds

Cat No. Product Name Synonyms Targets
T5817 PKC-theta inhibitor hcl PKC-theta inhibitor PKC
PKC-theta inhibitor hcl is a selective PKC-θinhibitor(IC50:12 nM).
TP1956L PKC ζ pseudosubstrate acetate PKC ζ pseudosubstrate acetate (799764-07-1 free base) PKC
PKC ζ pseudosubstrate acetate is an inhibitor of protein kinase C (PKC) ζ; attached to cell permeabilisation Antennapedia domain vector peptide. Consists of amino acids 113 - 129 of PKC ζ pseudosubstrate domain linked by...
TP1955L PKC β pseudosubstrate acetate Protein kinase C beta pseudosubstrate,PKC beta pseudosubstrate,PKC β pseudosubstrate acetate (172308-76-8 Free base) PKC
PKC β pseudosubstrate acetate (PKC β pseudosubstrate acetate (172308-76-8 Free base)) is a selective cell-permeable inhibitor of PKC.
T8764 PKC-iota inhibitor 1 PKC
PKC-iota inhibitor 1 is an inhibitor of protein kinase C-iota (PKC-ι ; IC50 : 0.34 μM)
T5423 PKC-theta inhibitor PKC
PKC-theta inhibitor is PKC-θinhibitor, with an IC50 of 12 nM.
T71993 PKC-9
PKC-9 is a PKC-zeta inhibitor 9.
T35826 PKC fragment (530-558)
PKC fragment (530-558) is a peptide fragment of protein kinase C (PKC) and is a potent PKC activator. Protein Kinase C (530-558) significantly inhibits osteoclastic bone resorption.
TP1955 PKC β pseudosubstrate
Selective cell-permeable peptide inhibitor of protein kinase C (IC50 ~ 0.5 μM). Consists of amino acids 19 - 31 of PKC pseudosubstrate domain linked by a disulphide bridge to a cell permeabilisation Antennapedia domain v...
T12494 PKC-IN-1 PKC
PKC-IN-1 is an ATP-competitive and reversible conventional PKC enzymes inhibitor (PKCα, PKCβI, PKCβII, PKCθ, PKCγ, PKC mu and PKCε with IC50s of 2.3, 8.1, 7.6, 25.6, 57.5, 314, 808 nM, respectively).
TP1956 PKC ζ pseudosubstrate
Inhibitor of protein kinase C (PKC) ζ; attached to cell permeabilisation Antennapedia domain vector peptide. Consists of amino acids 113 - 129 of PKC ζ pseudosubstrate domain linked by a disulphide bridge to the Antennap...
T12496 PKC-theta inhibitor 1 PKC
PKC-theta inhibitor 1 is an inhibitor of PKCθ (Ki of 6 nM)
TP1053L Protein Kinase C 19-31 acetate Protein Kinase C 19-31 acetate(121545-65-1 free base),PKC (19-31) acetate PKC
Protein Kinase C 19-31 acetate, a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is...
T61604 PKC-IN-4
PKC-IN-4 (compound 7l) is a highly potent and orally active inhibitor of atypical protein kinase C (aPKC), exhibiting an IC 50 value of 0.52 μM. In vitro studies have demonstrated that PKC-IN-4 effectively suppresses NF-...
T80509 PKC 20-28,myristoylated Myristoylated protein kinase C inhibitor 20-28 PKC
Myristoylated protein kinase C inhibitor 20-28 (PKC 20-28,myristoylated) is a cell-permeable inhibitor of protein kinase C, utilized in cancer research [1].
T75885 PKC β pseudosubstrate TFA
PKC β pseudosubstrate TFA is a selective cell-permeable inhibitor of PKC [1] .
T81449 PKC-ε translocation inhibitor peptide PKC
PKC-ε Translocation Inhibitor Peptide is a selective modulator that controls the FcγR-mediated internalization rate of opsonized beads without affecting FcαR trafficking [1].
T62945 Aurora A/PKC-IN-1
Aurora A/PKC-IN-1 (Compound 2e) is a potent dual inhibitor of Aurora A (AurA) and PKC (α, β1, β2, θ), acting on AurA (IC50: 6.9 nM) and PKCα (IC50: 16.9 nM). Aurora A/PKC-IN-1 showed anti-proliferative and anti-metastati...
T35407 Ζ-Stat PKC
ζ-Stat (NSC37044), a specific and atypical inhibitor of PKC-ζ with an IC50 of 5 μM, demonstrates the ability to inhibit proliferation and induce apoptosis in melanoma cell lines, exhibiting antitumor activity in vitro[1]...
T17148 TPPB PKC
TPPB is a kinase C activator of cell-permeable benzolactam-derived protein (Ki: 11.9 nM).
T5771 Hypocrellin A Antibacterial , PKC , Parasite
Hypocrellin A is PKC inhibitor, has light-induced antitumor,antifungal and antiviral activities, it also exerts immunomodulatory effects on MHC-restricted presentation of antigen.
1 2 3 4 5 6 7 8 9 10 11 12 13
TargetMol